Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
288
-
Total 13F shares, excl. options
-
81.6M
-
Shares change
-
+15.5M
-
Total reported value, excl. options
-
$1.34B
-
Value change
-
+$255M
-
Put/Call ratio
-
0.28
-
Number of buys
-
143
-
Number of sells
-
-77
-
Price
-
$16.48
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q1 2023
319 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q1 2023.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 288 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.6M shares
.
Largest 10 shareholders include Capital Research Global Investors (13.6M shares), MORGAN STANLEY (4.58M shares), Clal Insurance Enterprises Holdings Ltd (4.37M shares), GOLDMAN SACHS GROUP INC (4.35M shares), Mondrian Investment Partners LTD (4.08M shares), MACQUARIE GROUP LTD (3.91M shares), MILLENNIUM MANAGEMENT LLC (3.84M shares), RENAISSANCE TECHNOLOGIES LLC (2.97M shares), BlackRock Inc. (2.55M shares), and Point72 Asset Management, L.P. (2.53M shares).
This table shows the top 288 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.